phenelzine has been researched along with Syncope in 2 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgotas, A | 1 |
| McCue, RE | 1 |
| Hapworth, W | 1 |
| Friedman, E | 1 |
| Kim, OM | 1 |
| Welkowitz, J | 1 |
| Chang, I | 1 |
| Cooper, TB | 1 |
| Sethna, ER | 1 |
2 trials available for phenelzine and Syncope
| Article | Year |
|---|---|
Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
Topics: Aged; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nortriptyline; Phenelzine; | 1986 |
A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.
Topics: Adult; Amitriptyline; Body Weight; Clinical Trials as Topic; Depression; Drug Therapy, Combination; | 1974 |